Andrianopoulos Vasileios, Holland Anne E, Singh Sally J, Franssen Frits M E, Pennings Herman-Jan, Michels Arent J, Smeenk Frank W J M, Vogiatzis Ioannis, Wouters Emiel F M, Spruit Martijn A
Department of Research and Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Hornerheide, Horn, The Netherlands
Department of Physiotherapy, Alfred Health and La Trobe University, Melbourne, Australia.
Chron Respir Dis. 2015 May;12(2):111-9. doi: 10.1177/1479972315575201. Epub 2015 Mar 9.
The use of different 6-min walk distance (6MWD) reference equations probably results in different predicted 6MWD reference values. We wished to investigate the impact of several 6MWD reference equations for adults in patients with chronic obstructive pulmonary disease (COPD) and factors accountable for different 6MWD% predicted values. Twenty-two 6MWD reference equations were applied to a data set of 2757 patients with COPD. The predicted 6MWD reference value of Troosters and colleagues was used as the point of reference. Four out of 21 remaining equations resulted in comparable 6MWD% predicted, 16 equations resulted in significantly higher 6MWD% predicted and 1 equation resulted in a significantly lower 6MWD% predicted. Similar differences in 6MWD% predicted were observed after stratification by sex. Body mass index and global initiative for chronic obstructive lung disease (GOLD) stage classification demonstrated varying results within and between the groups; 9 out of 21 equations resulted in comparable 6MWD% predicted in underweight patients but only 1 equation demonstrated comparable result in obese. Eight equations in GOLD I, whilst 5 out of 21 equations in GOLD IV resulted in comparable 6MWD% predicted. Existing 6MWD reference equations will give varying results. The choice of 6MWD reference equation should consider the consistency of 6-min walk test operating procedures and at least be specific for the country/region of origin.
使用不同的6分钟步行距离(6MWD)参考方程可能会得出不同的预测6MWD参考值。我们希望研究几种适用于慢性阻塞性肺疾病(COPD)成年患者的6MWD参考方程的影响以及导致不同预测6MWD%值的因素。将22个6MWD参考方程应用于2757例COPD患者的数据集。以特罗斯特斯及其同事预测的6MWD参考值作为参照标准。其余21个方程中有4个得出的预测6MWD%相当,16个方程得出的预测6MWD%显著更高,1个方程得出的预测6MWD%显著更低。按性别分层后,在预测6MWD%方面也观察到了类似差异。体重指数和慢性阻塞性肺疾病全球倡议(GOLD)分期分类在组内和组间显示出不同结果;21个方程中有9个在体重过轻的患者中得出的预测6MWD%相当,但在肥胖患者中只有1个方程得出了相当的结果。在GOLD I期有8个方程,而在GOLD IV期21个方程中有5个得出的预测6MWD%相当。现有的6MWD参考方程会得出不同的结果。6MWD参考方程的选择应考虑6分钟步行试验操作程序的一致性,并且至少要针对其原产国/地区具有特异性。